Here is what the page “Unseen Burden: Alarming Waste in Clinical Trial Data Collection Revealed | Nova Global New” contains. Clinical trials, vital for medical breakthroughs, are plagued by a significant inefficiency: nearly 30% of painstakingly collected data remains unused. This 'unseen burden' represents a substantial financial drain on the pharmaceutical and biotechnology industries and raises profound ethical questions regarding patient participation. The article highlights that this data waste not only erodes resources but also burdens patients, calling for urgent introspection and a more streamlined, patient-centric approach to clinical research to address this silent inefficiency. Nova Global News curates publicly available headlines and summaries with source attribution.
Third-party article rights, trademarks, images, and publisher names belong to their respective owners; read the original article at the source for full context. Part of the Nova Ecosystem — the platform where AI apps, news, and tools are built and deployed. The full version stays on the original page, which this listing opens directly.